Lenalidomide is a cornerstone therapy for multiple myeloma (MM) and other hematologic malignancies, but conventional oral dosing is limited by high peak plasma concentrations, rapid clearance, and ...

Please provide your email address to receive an email when new articles are posted on . Researchers have discovered a link between neurotoxicity related to chimeric antigen receptor T-cell therapy and ...

Low-dose Revlimid delayed transfusion dependency and improved treatment response rates in non-transfusion dependent MDS patients. Revlimid reduced the risk of transfusion dependency by 69.8% compared ...

Hypophosphatemia refers to abnormally low levels of phosphate in the blood. Often, a person is unaware they have this condition and may not present with symptoms. This article explores ...